Loading...
Mettler-Toledo International Inc.
MTD•NYSE
Healthcare
Medical - Diagnostics & Research
$1197.23
$-36.45(-2.95%)
Mettler-Toledo International Inc. (MTD) Financial Performance & Income Statement Overview
Review Mettler-Toledo International Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.22%
↑ 2.22%
Operating Income Growth
-2.16%
↓ 2.16%
Net Income Growth
9.43%
↑ 9.43%
Operating Cash Flow Growth
0.26%
↑ 0.26%
Operating Margin
30.69%
↑ 30.69%
Gross Margin
59.94%
↑ 59.94%
Net Profit Margin
21.46%
↑ 21.46%
ROE
113.00%
↑ 113.00%
ROIC
51.74%
↑ 51.74%
Mettler-Toledo International Inc. (MTD) Income Statement & Financial Overview
Review Mettler-Toledo International Inc.'s (MTD) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $883.74M | $1.05B | $954.53M | $946.75M |
| Cost of Revenue | $357.87M | $405.81M | $382.07M | $399.26M |
| Gross Profit | $525.88M | $639.32M | $572.47M | $547.49M |
| Gross Profit Ratio | $0.60 | $0.61 | $0.60 | $0.58 |
| R&D Expenses | $46.35M | $50.05M | $47.12M | $45.77M |
| SG&A Expenses | $242.80M | $237.34M | $228.78M | $235.80M |
| Operating Expenses | $289.14M | $287.39M | $275.89M | $281.57M |
| Total Costs & Expenses | $647.01M | $656.80M | $657.96M | $680.83M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $16.65M | $17.85M | $18.60M | $18.95M |
| Depreciation & Amortization | $18.14M | $30.86M | $31.08M | $30.53M |
| EBITDA | $236.73M | $363.26M | $308.63M | $295.76M |
| EBITDA Ratio | $0.27 | $0.35 | $0.32 | $0.31 |
| Operating Income | $236.73M | $333.70M | $332.98M | $265.92M |
| Operating Income Ratio | $0.27 | $0.32 | $0.35 | $0.28 |
| Other Income/Expenses (Net) | -$34.79M | -$19.15M | -$74.03M | -$22.75M |
| Income Before Tax | $201.94M | $314.55M | $258.95M | $243.18M |
| Income Before Tax Ratio | $0.23 | $0.30 | $0.27 | $0.26 |
| Income Tax Expense | $38.35M | $62.25M | $47.44M | $21.36M |
| Net Income | $163.59M | $252.30M | $211.52M | $221.81M |
| Net Income Ratio | $0.19 | $0.24 | $0.22 | $0.23 |
| EPS | $7.84 | $12.00 | $9.94 | $10.42 |
| Diluted EPS | $7.84 | $11.96 | $9.94 | $10.37 |
| Weighted Avg Shares Outstanding | $20.87M | $21.02M | $21.29M | $21.28M |
| Weighted Avg Shares Outstanding (Diluted) | $20.87M | $21.10M | $21.29M | $21.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan